These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 27098984)
1. Adjuvant radiotherapy versus concurrent chemoradiotherapy for the management of high-risk salivary gland carcinomas. Mifsud MJ; Tanvetyanon T; Mccaffrey JC; Otto KJ; Padhya TA; Kish J; Trotti AM; Harrison LB; Caudell JJ Head Neck; 2016 Nov; 38(11):1628-1633. PubMed ID: 27098984 [TBL] [Abstract][Full Text] [Related]
2. Association of Adjuvant Chemoradiotherapy vs Radiotherapy Alone With Survival in Patients With Resected Major Salivary Gland Carcinoma: Data From the National Cancer Data Base. Amini A; Waxweiler TV; Brower JV; Jones BL; McDermott JD; Raben D; Ghosh D; Bowles DW; Karam SD JAMA Otolaryngol Head Neck Surg; 2016 Nov; 142(11):1100-1110. PubMed ID: 27541166 [TBL] [Abstract][Full Text] [Related]
3. Adjuvant chemoradiotherapy versus with radiotherapy alone for locally advanced salivary gland carcinoma among older patients. Tanvetyanon T; Fisher K; Caudell J; Otto K; Padhya T; Trotti A Head Neck; 2016 Jun; 38(6):863-70. PubMed ID: 26340707 [TBL] [Abstract][Full Text] [Related]
4. Concurrent Chemoradiotherapy in the Adjuvant Treatment of High-risk Primary Salivary Gland Malignancies. Gebhardt BJ; Ohr JP; Ferris RL; Duvvuri U; Kim S; Johnson JT; Heron DE; Clump DA Am J Clin Oncol; 2018 Sep; 41(9):888-893. PubMed ID: 28394767 [TBL] [Abstract][Full Text] [Related]
5. Salivary gland tumors treated with adjuvant intensity-modulated radiotherapy with or without concurrent chemotherapy. Schoenfeld JD; Sher DJ; Norris CM; Haddad RI; Posner MR; Balboni TA; Tishler RB Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):308-14. PubMed ID: 21075557 [TBL] [Abstract][Full Text] [Related]
6. Adjuvant Therapy for Salivary Gland Carcinomas. Sayan M; Vempati P; Miles B; Teng M; Genden E; Demicco EG; Misiukiewicz K; Posner M; Gupta V; Bakst RL Anticancer Res; 2016 Aug; 36(8):4165-70. PubMed ID: 27466526 [TBL] [Abstract][Full Text] [Related]
7. Management and outcome of patients with malignant salivary gland tumors. Bell RB; Dierks EJ; Homer L; Potter BE J Oral Maxillofac Surg; 2005 Jul; 63(7):917-28. PubMed ID: 16003616 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of the efficacy of adjuvant radiotherapy versus chemoradiotherapy in patients with salivary gland tumors. Aral İP; İnan GA; Gökçe E; Gani Z; Ergün D; Arslan N; Akinci MB; Tezcan Y J Cancer Res Ther; 2024 Apr; 20(3):850-857. PubMed ID: 38261449 [TBL] [Abstract][Full Text] [Related]
10. Concurrent chemoradiotherapy for locoregionally advanced salivary gland malignancies. Rosenberg L; Weissler M; Hayes DN; Shockley W; Zanation A; Rosenman J; Chera B Head Neck; 2012 Jun; 34(6):872-6. PubMed ID: 22127998 [TBL] [Abstract][Full Text] [Related]
11. Prognostic value of lymph node density in high-grade salivary gland cancers. Hong HR; Roh JL; Cho KJ; Choi SH; Nam SY; Kim SY J Surg Oncol; 2015 May; 111(6):784-9. PubMed ID: 25640975 [TBL] [Abstract][Full Text] [Related]
12. Chemoradiotherapy versus radiotherapy in high risk salivary gland cancer. Shen Y; Shan J World J Surg Oncol; 2024 Jul; 22(1):181. PubMed ID: 38992685 [TBL] [Abstract][Full Text] [Related]
13. The role of adjuvant therapy in the management of head and neck merkel cell carcinoma: an analysis of 4815 patients. Chen MM; Roman SA; Sosa JA; Judson BL JAMA Otolaryngol Head Neck Surg; 2015 Feb; 141(2):137-41. PubMed ID: 25474617 [TBL] [Abstract][Full Text] [Related]
14. Treatment outcomes in metastatic and localized high-grade salivary gland cancer: high chance of cure with surgery and post-operative radiation in T1-2 N0 high-grade salivary gland cancer. Jang JY; Choi N; Ko YH; Chung MK; Son YI; Baek CH; Baek KH; Jeong HS BMC Cancer; 2018 Jun; 18(1):672. PubMed ID: 29925355 [TBL] [Abstract][Full Text] [Related]
15. Outcome and management of rare high-grade "salivary" adenocarcinoma: the important role of adjuvant (chemo)radiotherapy. Scherl C; Haderlein M; Agaimy A; Mantsopoulos K; Koch M; Traxdorf M; Fietkau R; Grundtner P; Iro H Strahlenther Onkol; 2019 Dec; 195(12):1050-1059. PubMed ID: 31350567 [TBL] [Abstract][Full Text] [Related]
17. Outcomes of postoperative concurrent chemoradiotherapy for locally advanced major salivary gland carcinoma. Tanvetyanon T; Qin D; Padhya T; McCaffrey J; Zhu W; Boulware D; DeConti R; Trotti A Arch Otolaryngol Head Neck Surg; 2009 Jul; 135(7):687-92. PubMed ID: 19620591 [TBL] [Abstract][Full Text] [Related]
18. Postoperative Chemoradiation Therapy in High-Risk Cervical Cancer: Re-evaluating the Findings of Gynecologic Oncology Group Study 109 in a Large, Population-Based Cohort. Trifiletti DM; Swisher-McClure S; Showalter TN; Hegarty SE; Grover S Int J Radiat Oncol Biol Phys; 2015 Dec; 93(5):1032-44. PubMed ID: 26581141 [TBL] [Abstract][Full Text] [Related]
19. Adding concurrent chemotherapy to postoperative radiotherapy improves locoregional control but Not overall survival in patients with salivary gland adenoid cystic carcinoma-a propensity score matched study. Hsieh CE; Lin CY; Lee LY; Yang LY; Wang CC; Wang HM; Chang JT; Fan KH; Liao CT; Yen TC; Fang KH; Tsang YM Radiat Oncol; 2016 Mar; 11():47. PubMed ID: 27000157 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of Surgical Margin Status in Patients With Salivary Gland Cancer. Hanson M; McGill M; Mimica X; Eagan A; Hay A; Wu J; Cohen MA; Patel SG; Ganly I JAMA Otolaryngol Head Neck Surg; 2022 Feb; 148(2):128-138. PubMed ID: 34854898 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]